Q BioMed Announces Strategic Partnership with SRI International for Formulation and Preclinical Deve...December-12-2018
Collaboration with SRI Provides Q BioMed Expertise in Formulation Development and Preclinical Work in...November-28-2018
Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22...Q BioMed Takes the Stage in the Expanded Access Debate at European Early and Managed Access Program ...October-26-2018
Q BioMed Orphan Drug VP, who started the first Expanded Access Program Database asked to Speak on...
RECENT SEC FILINGS
Description Form Date 8-K Current report 2019-01-07 EFFECT Notice of Effectiveness 2018-12-26 S-1/A General form for registration of securities under the Securities Act of 1933 2018-12-13 CT ORDER Confidential treatment order 2018-12-06 8-K Current report 2018-11-28 8-K Current report 2018-11-02 S-1 General form for registration of securities under the Securities Act of 1933 2018-10-25 10-Q/A Quarterly report [Sections 13 or 15(d)]
2018-10-19 10-Q Quarterly report [Sections 13 or 15(d)] 2018-10-15 8-K Current report 2018-09-24